Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
Synonyms	DIPNECH
Pronounce	N/A
Specialty	N/A
Symptoms	Cough, dyspnea, wheezing
Complications	Obstructive lung disease, carcinoid tumors
Onset	Middle-aged adults
Duration	Chronic
Types	N/A
Causes	Unknown
Risks
Diagnosis	High-resolution computed tomography, lung biopsy
Differential diagnosis	Asthma, chronic obstructive pulmonary disease, bronchitis
Prevention	N/A
Treatment	Corticosteroids, bronchodilators, surgery
Medication
Prognosis	Variable, can be progressive
Frequency	Rare
Deaths	N/A

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare pulmonary disorder characterized by the proliferation of neuroendocrine cells within the lungs. This condition is considered a precursor to neuroendocrine tumors and is often associated with obstructive lung disease.

Pathophysiology

DIPNECH involves the diffuse proliferation of neuroendocrine cells in the bronchiolar epithelium. These cells can form small nodules known as tumorlets, which are less than 5 mm in diameter. The condition is thought to be a precursor to carcinoid tumors, which are a type of neuroendocrine tumor. The exact cause of DIPNECH is unknown, but it is considered idiopathic, meaning it arises spontaneously without a known cause.

Clinical Presentation

Patients with DIPNECH often present with symptoms of chronic cough, dyspnea (shortness of breath), and sometimes wheezing. These symptoms are due to the obstruction of airways by the proliferating neuroendocrine cells and tumorlets. In some cases, patients may be asymptomatic, and the condition is discovered incidentally during imaging studies for other reasons.

Diagnosis

The diagnosis of DIPNECH is typically made through a combination of clinical evaluation, imaging studies, and histopathological examination. High-resolution computed tomography (HRCT) of the chest may reveal multiple small nodules and areas of air trapping. A lung biopsy is often required to confirm the diagnosis, showing the characteristic proliferation of neuroendocrine cells and the presence of tumorlets.

Treatment

There is no standard treatment for DIPNECH, and management is often tailored to the individual patient. Options may include observation for asymptomatic patients, bronchodilators and corticosteroids for symptomatic relief, and in some cases, surgical resection of larger lesions. The use of somatostatin analogs has been explored in some cases to control symptoms and slow disease progression.

Prognosis

The prognosis for patients with DIPNECH varies. Some patients may experience stable disease with minimal symptoms, while others may progress to develop more significant obstructive lung disease or neuroendocrine tumors. Regular follow-up with pulmonary function tests and imaging studies is often recommended to monitor disease progression.

Related pages

• Neuroendocrine tumor
• Carcinoid tumor
• Obstructive lung disease
• Chronic cough